Myles Lawless
Sr. Director, Digital and Omnichannel Marketing
Corcept Therapeutics
Making Digital Better—Every Day
Corcept Therapeutics, a pharmaceutical company focused on unlocking the potential of cortisol modulation, has built much of its current marketing success through a combination of traditional marketing with limited digital marketing, and face-to-face sales. However, with a robust clinical pipeline and a changing competitive landscape, it was clear the future required a different approach. Enter Myles Lawless, Senior Director, Digital and Omnichannel Marketing. As the company’s first-ever marketer focused on digital and omnichannel efforts, Myles has already set the company on a powerful new digital trajectory.
Myles leads Corcept in the development and deployment of an integrated omnichannel strategy, technology infrastructure, digital execution standardization, and data and analytics for the
endocrinology organization. Through active listening and education with stakeholders, he has led the organization in creating a unified digital and omnichannel road map that elevates the orchestration of audiences’ beliefs and needs, impactful messaging and maximization of channel integration for effective personalization to HCP and patient audiences, while also simplifying internal ecosystem complexity.
“Myles leads Corcept in the development and deployment of an integrated omnichannel strategy, technology infrastructure, digital execution standardization, and data and analytics for the endocrinology organization.”
For example, in partnership with EVERSANA INTOUCH, Myles championed expanding Corcept’s digital media advertising channel mix resulting in a 365% increase in funding for proposed expanded digital media advertising channel mix. He implemented an enterprise-wide cookie management and privacy preference platform, and created an enterprise-wide search engine marketing governance model, which in turn drove a 100% increase in corporate funding for newly targeted SEM campaigns and reduced technology ecosystem complexity by 30%.
Myles and the endocrine marketing team’s strategic initiatives exemplify a holistic approach to digital transformation, where strategy, technology, execution and data converge to elevate the business’s impact and foster meaningful connections. Under his leadership, Corcept is reaching levels of digital sophistication that position the company for continued success.
Myles has supported multiple new product launches in U.S. and EU markets. He has implemented digital core sales aids and interactive visual aids, automated marketing- and sales-driven email CRM programs, integrated claims-based data insights and automated next-best action (NBA) non-personal- and personal- promotion, integrated multichannel media plans, enterprise data analytics, and insights reporting tools.
